IRIS Accounts Production v24.1.0.578 SC437175 director 1.12.22 30.11.23 30.11.23 0 0 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC4371752022-11-30SC4371752023-11-30SC4371752022-12-012023-11-30SC4371752021-11-30SC4371752021-12-012022-11-30SC4371752022-11-30SC437175ns15:Scotland2022-12-012023-11-30SC437175ns14:PoundSterling2022-12-012023-11-30SC437175ns10:Director12022-12-012023-11-30SC437175ns10:PrivateLimitedCompanyLtd2022-12-012023-11-30SC437175ns10:SmallEntities2022-12-012023-11-30SC437175ns10:AuditExempt-NoAccountantsReport2022-12-012023-11-30SC437175ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-30SC437175ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-30SC437175ns10:FullAccounts2022-12-012023-11-30SC437175ns10:RegisteredOffice2022-12-012023-11-30SC437175ns5:CurrentFinancialInstruments2023-11-30SC437175ns5:CurrentFinancialInstruments2022-11-30SC437175ns5:ShareCapital2023-11-30SC437175ns5:ShareCapital2022-11-30SC437175ns5:FurtherSpecificReserve3ComponentTotalEquity2023-11-30SC437175ns5:FurtherSpecificReserve3ComponentTotalEquity2022-11-30SC437175ns5:RetainedEarningsAccumulatedLosses2023-11-30SC437175ns5:RetainedEarningsAccumulatedLosses2022-11-30SC437175ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-11-30SC437175ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-11-30SC437175ns5:CurrentFinancialInstruments2022-12-012023-11-30SC437175ns5:RetainedEarningsAccumulatedLosses2022-11-30SC437175ns5:FurtherSpecificReserve3ComponentTotalEquity2022-11-30SC437175ns5:RetainedEarningsAccumulatedLosses2022-12-012023-11-30
REGISTERED NUMBER: SC437175 (Scotland)



















PCR INVESTMENTS LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

30 NOVEMBER 2023






PCR INVESTMENTS LIMITED (REGISTERED NUMBER: SC437175)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


PCR INVESTMENTS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 NOVEMBER 2023







DIRECTOR: Ms Cesilia Yin Ping Chui





REGISTERED OFFICE: 9 Royal Crescent
Glasgow
G3 7SP





REGISTERED NUMBER: SC437175 (Scotland)





ACCOUNTANTS: Whitelaw Wells
Chartered Accountants
9 Royal Crescent
Glasgow
G3 7SP

PCR INVESTMENTS LIMITED (REGISTERED NUMBER: SC437175)

BALANCE SHEET
30 NOVEMBER 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Investment property 3 1,200,000 1,200,000

CURRENT ASSETS
Debtors 4 459,092 459,092
Cash at bank 38,143 30,137
497,235 489,229
CREDITORS
Amounts falling due within one year 5 774,134 889,495
NET CURRENT LIABILITIES (276,899 ) (400,266 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

923,101

799,734

PROVISIONS FOR LIABILITIES 37,364 37,364
NET ASSETS 885,737 762,370

CAPITAL AND RESERVES
Called up share capital 100 100
Fair value reserve 6 118,320 118,320
Retained earnings 6 767,317 643,950
SHAREHOLDERS' FUNDS 885,737 762,370

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

PCR INVESTMENTS LIMITED (REGISTERED NUMBER: SC437175)

BALANCE SHEET - continued
30 NOVEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 11 July 2024 and were signed by:





Ms Cesilia Yin Ping Chui - Director


PCR INVESTMENTS LIMITED (REGISTERED NUMBER: SC437175)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023


1. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover and revenue recognition
The turnover shown in the profit and loss account represents the rental income receivable for the year. Income is recognised on the basis of rent due for the year.

Investment property
Investment properties are shown at their fair value. The surplus or deficit arising from changes in fair value are recognised in the profit and loss account for the year. A reduction in value due to fluctuation in the property market is not considered to be permanent.

This is in accordance with FRS102 which, unlike the Companies Act 2006, does not require depreciation of investment properties. Investment properties are held for their investment potential and not for use by the company and so their current value is of prime importance.

Deferred taxation is provided on any fair value surplus at the rate expected to apply when the property is sold and at the year end is included in the fair value reserve together with the fair value movement.

Financial instruments
Basic financial instruments such as cash, debtors and creditors are measured at transaction price. Financial liabilities classified as payable within one year are not amortised.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

PCR INVESTMENTS LIMITED (REGISTERED NUMBER: SC437175)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2023


2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

3. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 December 2022
and 30 November 2023 1,200,000
NET BOOK VALUE
At 30 November 2023 1,200,000
At 30 November 2022 1,200,000

Fair value at 30 November 2023 is represented by:
£   
Valuation in 2017 55,684
Valuation in 2020 100,000
Cost 1,044,316
1,200,000

The investment property was revalued by the director on 30 November 2020 and the valuation at November 2023 remains unchanged.

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other debtors 528 528
Loan to related companies 418,360 418,360
Tax recoverable 204 204
Prepayments and accrued income 40,000 40,000
459,092 459,092

The other debtors and related company loan are interest free and repayable on demand.

PCR INVESTMENTS LIMITED (REGISTERED NUMBER: SC437175)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2023


5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Corporation Tax 35,697 31,094
Other loans 466,567 466,567
Loans from shareholder 41,696 101,696
Loans from related companies 229,232 289,232
Accrued expenses 942 906
774,134 889,495

The loans are interest free and repayable on demand.

6. RESERVES
Fair
Retained value
earnings reserve Totals
£    £    £   

At 1 December 2022 643,950 118,320 762,270
Profit for the year 123,367 123,367
At 30 November 2023 767,317 118,320 885,637

7. RELATED PARTY DISCLOSURES

The loan balance due from a former director amounted to £528 (2022 : £528) at the year end.

The loan balance due to a shareholder amounted to £41,696 (2022 : £101,696) at the year end.